Research ExplorerPublicationsEffect of vitamin D3 treatment on bone density in neurofibro...

Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study.

Standard

Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study. / Schnabel, Claudia; Jett, Kimberly; Friedman, Jan M; Frieling, Isolde; Kruse, Hans-Peter; Mautner, Viktor Felix.

In: JOINT BONE SPINE, Vol. 80, No. 3, 3, 2013, p. 315-319.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schnabel, C, Jett, K, Friedman, JM, Frieling, I, Kruse, H-P & Mautner, VF 2013, 'Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study.', JOINT BONE SPINE, vol. 80, no. 3, 3, pp. 315-319. <http://www.ncbi.nlm.nih.gov/pubmed/23021159?dopt=Citation>

APA

Schnabel, C., Jett, K., Friedman, J. M., Frieling, I., Kruse, H-P., & Mautner, V. F. (2013). Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study. JOINT BONE SPINE, 80(3), 315-319. [3]. http://www.ncbi.nlm.nih.gov/pubmed/23021159?dopt=Citation

Vancouver

Schnabel C, Jett K, Friedman JM, Frieling I, Kruse H-P, Mautner VF. Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study. JOINT BONE SPINE. 2013;80(3):315-319. 3.

Bibtex

@article{dcb85dbc4df64c37bb1403842fc663cf,
title = "Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study.",
abstract = "We have previously demonstrated reduced bone density and an increased incidence of 25-hydroxy vitamin D3 (25-OH D3) deficiency in adults with neurofibromatosis 1 (NF1) compared to healthy controls. Vitamin D3 is a cheap, safe, and effective supplement in the general population, but its value in NF1 patients has not been demonstrated. This study investigates the therapeutic potential of oral vitamin D3 on bone mineral density (BMD) in NF1 patients with vitamin D3 deficiency.",
author = "Claudia Schnabel and Kimberly Jett and Friedman, {Jan M} and Isolde Frieling and Hans-Peter Kruse and Mautner, {Viktor Felix}",
year = "2013",
language = "English",
volume = "80",
pages = "315--319",
journal = "JOINT BONE SPINE",
issn = "1297-319X",
publisher = "Elsevier Masson",
number = "3",

}

RIS

TY - JOUR

T1 - Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study.

AU - Schnabel, Claudia

AU - Jett, Kimberly

AU - Friedman, Jan M

AU - Frieling, Isolde

AU - Kruse, Hans-Peter

AU - Mautner, Viktor Felix

PY - 2013

Y1 - 2013

N2 - We have previously demonstrated reduced bone density and an increased incidence of 25-hydroxy vitamin D3 (25-OH D3) deficiency in adults with neurofibromatosis 1 (NF1) compared to healthy controls. Vitamin D3 is a cheap, safe, and effective supplement in the general population, but its value in NF1 patients has not been demonstrated. This study investigates the therapeutic potential of oral vitamin D3 on bone mineral density (BMD) in NF1 patients with vitamin D3 deficiency.

AB - We have previously demonstrated reduced bone density and an increased incidence of 25-hydroxy vitamin D3 (25-OH D3) deficiency in adults with neurofibromatosis 1 (NF1) compared to healthy controls. Vitamin D3 is a cheap, safe, and effective supplement in the general population, but its value in NF1 patients has not been demonstrated. This study investigates the therapeutic potential of oral vitamin D3 on bone mineral density (BMD) in NF1 patients with vitamin D3 deficiency.

M3 - SCORING: Journal article

VL - 80

SP - 315

EP - 319

JO - JOINT BONE SPINE

JF - JOINT BONE SPINE

SN - 1297-319X

IS - 3

M1 - 3

ER -